Insight Molecular Diagnos... (IMDX)
NASDAQ: IMDX
· Real-Time Price · USD
3.06
0.04 (1.32%)
At close: Jul 01, 2025, 3:56 PM
3.04
-0.65%
After-hours: Jul 01, 2025, 04:04 PM EDT
1.32% (1D)
| Bid | 2.98 |
| Market Cap | 87.51M |
| Revenue (ttm) | 3.84M |
| Net Income (ttm) | -58.2M |
| EPS (ttm) | -3.79 |
| PE Ratio (ttm) | -0.81 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 3.15 |
| Volume | 21,549 |
| Avg. Volume (20D) | 78,847 |
| Open | 2.99 |
| Previous Close | 3.02 |
| Day's Range | 2.98 - 3.10 |
| 52-Week Range | 1.92 - 4.75 |
| Beta | 0.99 |
About IMDX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IMDX
Website n/a
Next Earnings Release
Insight Molecular Diagnostics Inc. is scheduled to release its earnings on Aug 7, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago · prismmediawire.com
Oncocyte to Participate in 24th Annual Needham Virtual Healthcare ConferenceIRVINE, Calif., April 2, 2025 – PRISM MediaWire – Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Of...